|Click here for Webcast|
Q4 2017 Xtant Medical Holdings Inc Earnings Conference Call (Replay)
04/03/18 at 9:00 a.m. ET
|2018 | 2017 | 2016 | 2015 | 2014|
Xtant Medical Holdings, Inc. Announces Record Date for Proposed Rights Offering
BELGRADE, MT / ACCESSWIRE / April 17, 2018 / Xtant™ Medical Holdings, Inc. (NYSE American: XTNT) announced today that it has set April 27, 2018 as the record date for a proposed rights offering of its shares of common stock.At the commencement of the...
Xtant Announces Fourth Quarter and Year End 2017 Financial Results
BELGRADE, MT / ACCESSWIRE / April 2, 2018 / Xtant™ Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, today reported its financial results for the period ended December 31s...
Xtant Medical to Issue Fourth Quarter and Full Year 2017 Financial Results Monday, April 2
BELGRADE, MT / ACCESSWIRE / March 27, 2018 / Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that it will release its financial results for the fou...
Xtant Medical Announces Compliance with NYSE American
Reports Pro Forma Stockholders’ Equity of approximately $47.4M as of 2/15/18 Xtant has regained compliance with the NYSE American listing standards BELGRADE, Mont., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Xtant™ Medical Holdings, Inc. (NYSE America...
Xtant Medical Announces Exchange of Outstanding Convertible Notes and Closing of Private Placement
Exchange of $70.238M (plus interest) of convertible notes into 10,401,309 shares of common stock at $7.20 per share. $6.809M Private Placement representing 945,819 shares of common stock at $7.20 per share. BELGRADE, Mont., Feb. 14, 2018 (GLO...
Xtant Medical Announces Results of Special Meeting of Stockholders
Approval of the issuance of new shares of common stock, as required by the NYSE American. Approval of an amendment to its certificate of incorporation, enabling its previously announced 1:12 reverse stock split. Approval of new directors to...
Xtant Medical Enters into Restructuring and Exchange Agreement with All Holders of Outstanding Convertible Notes
Conversion of $1.627M (plus interest) of convertible notes into common stock Exchange of $70.238M (plus interest) of convertible notes into common stock Upon stockholder approval, amendment of Certificate of Incorporation to effect reverse st...